Small Scale Bioreactors Market is Anticipated to Witness High Growth Owing to Increasing R&D Activities in Pharmaceutical Industry
![]() |
Small Scale Bioreactors Market |
Small
scale bioreactors are used widely in the biopharmaceutical industry for cell
culture process development and culture of mammalian and microbial cells for
vaccine and therapeutic protein production. They offer controlled environment
for cell growth and metabolite production on a small scale. The products
developed find vast applications in the manufacturing of vaccines, antibodies,
recombinant proteins and other biologics. The need for small scale bioreactors
stems from the requirement of evaluating process parameters and cell line
characterization at a small laboratory scale before commercial production. With
growing emphasis on developing new biologics for treatment of various diseases,
R&D investment and activities in the pharmaceutical industry have increased
significantly. This factors is expected to propel the demand for small scale
bioreactors for laboratory testing.
The Global
Small Scale Bioreactors Market Demand is estimated to be valued at US$
1738.21 Mn in 2024 and is expected to exhibit a CAGR of 3.8% over the forecast
period 2024 to 2031.
Key Takeaways
Key players operating in the Small Scale Bioreactors market are LabCorp, Quest
Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA,
DiaSorin S.p.A, T2 Biosystems, Inc., F. Hoffmann-La Roche AG, Meridian
Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. These
established players are focusing on new product launches and expansion of their
manufacturing facilities across major markets to strengthen their global
presence.
The growing burden of infectious diseases and various developments for
manufacturing novel biologics for treatment indicate a period of sustained
growth and opportunity in the coming years. Emergence of contract manufacturing
and partnership models are expected to boost capacity utilization.
North America is expected to continue dominating the small scale bioreactor
market owing to large biopharmaceutical industry and high R&D spending.
However, Asia Pacific is anticipated to witness highest growth due to
increasing outsourcing of bioproduction to China and India by major players and
establishment of manufacturing plants by global companies in these regions.
Market drivers and restraints
One of the key drivers for small scale bioreactors market is increasing
adoption of single-use bioreactors. They offer significant advantages over
conventional stainless steel bioreactors like lower capital investment and
reduced cleaning and validation requirements. Their use allows for lower volume
processing which is suitable for early stage process development.
High costs associated with single-use bioreactors pose a major challenge to
widespread adoption. Limited reusability increases overall production costs.
Additional costs are incurred for disposal of plastic consumables which
negatively impacts small scale bioproduction budgets. Biocompatibility issues
also remain a concern with leachables from plastics affecting cell growth and
product purity. These factors may restrain growth of the small scale
bioreactors market to some extent.
Segment
Analysis
The small-scale bioreactors market can be segmented into <100L, 100L-1KL,
1KL-5KL bioreactors based on capacity. The <100L bioreactors sub-segment
currently dominates the market due to its widespread application in research
activities, pre-clinical research, and process development studies. These
bioreactors facilitate research procedures and experiments with smaller
volumes, reducing the costs associated with such processes. They help minimize
the material requirements and enhance process flexibility to cater to changing
needs of research studies.
Global Analysis
In terms of regional analysis, North America is anticipated to register the
fastest growth in the small-scale bioreactors market during the forecast
period. This is attributable to the increasing adoption of technologically
advanced bioreactors, considerable healthcare infrastructure, and higher
healthcare spending across the region. Additionally, the presence of leading
small-scale bioreactors manufacturers and well-established biopharmaceutical
industry also support the market growth in North America. Asia Pacific is
expected to emerge as the second largest and one of the fastest growing
regional markets by 2031, driven majorly by supportive government initiatives
and funding towards pharmaceutical research in countries like China and India.
Get more insights on this topic: Small
Scale Bioreactors Market
Comments
Post a Comment